DekaBank Deutsche Girozentrale’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-80,000
| Closed | -$3.13M | – | 1550 |
|
|
2023
Q2 | $3.13M | Hold |
80,000
| – | – | 0.01% | 661 |
|
|
2023
Q1 | $1.88M | Buy |
80,000
+40,000
| +100% | +$876K | ﹤0.01% | 733 |
|
|
2022
Q4 | $825K | Hold |
40,000
| – | – | ﹤0.01% | 929 |
|
|
2022
Q3 | $682K | Sell |
40,000
-75,700
| -65% | -$994K | ﹤0.01% | 982 |
|
|
2022
Q2 | $1.09M | Buy |
115,700
+38,000
| +49% | +$477K | ﹤0.01% | 860 |
|
|
2022
Q1 | $1.27M | Buy |
77,700
+48,900
| +170% | +$723K | ﹤0.01% | 863 |
|
|
2021
Q4 | $466K | Buy |
28,800
+800
| +3% | +$13.1K | ﹤0.01% | 1115 |
|
|
2021
Q3 | $433K | Hold |
28,000
| – | – | ﹤0.01% | 1084 |
|
|
2021
Q2 | $167K | Hold |
28,000
| – | – | ﹤0.01% | 1254 |
|
|
2021
Q1 | $162K | Hold |
28,000
| – | – | ﹤0.01% | 1224 |
|
|
2020
Q4 | $181K | Buy |
+28,000
| New | +$179K | ﹤0.01% | 1194 |
|
|
2018
Q1 | – | Sell |
-26,400
| Closed | -$74K | – | 1225 |
|
|
2017
Q4 | $74K | Hold |
26,400
| – | – | ﹤0.01% | 1003 |
|
|
2017
Q3 | $74K | Hold |
26,400
| – | – | ﹤0.01% | 1011 |
|
|
2017
Q2 | $69K | Hold |
26,400
| – | – | ﹤0.01% | 989 |
|
|
2017
Q1 | $95K | Sell |
26,400
-2,000
| -7% | -$8.45K | ﹤0.01% | 905 |
|
|
2016
Q4 | $138K | Sell |
28,400
-2,750
| -9% | -$81.6K | ﹤0.01% | 890 |
|
|
2016
Q3 | $1.69M | Sell |
31,150
-25,000
| -45% | -$1.41M | 0.02% | 468 |
|
|
2016
Q2 | $2.92M | Buy |
56,150
+41,100
| +273% | +$2.04M | 0.03% | 399 |
|
|
2016
Q1 | $617K | Sell |
15,050
-2,600
| -15% | -$132K | 0.01% | 620 |
|
|
2015
Q4 | $1.38M | Buy |
17,650
+350
| +2% | +$20.2K | 0.02% | 519 |
|
|
2015
Q3 | $701K | Buy |
17,300
+950
| +6% | +$50.3K | 0.01% | 613 |
|
|
2015
Q2 | $851K | Buy |
16,350
+600
| +4% | +$29.8K | 0.01% | 593 |
|
|
2015
Q1 | $733K | Buy |
+15,750
| New | +$818K | 0.01% | 625 |
|
DekaBank Deutsche Girozentrale's ISEE Position: Q3 2023 in Review
DekaBank Deutsche Girozentrale sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 80,000 shares — an estimated $3.13M sold.
DekaBank Deutsche Girozentrale first reported a position in ISEE in Q1 2015 and held it in 23 quarters. The position peaked at $3.13M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- DekaBank Deutsche Girozentrale reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 80,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.13M.
- DekaBank Deutsche Girozentrale first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 23 quarters.
- DekaBank Deutsche Girozentrale's IVERIC bio, Inc. Common Stock position peaked at $3.13M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2023, filed 13 Nov 2023.